Delivery Order SPE2D119D7003-SPE2D524F408A

Award Date 8/26/24
Potential Completion Date 11/21/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Chelmsford, MA 01824, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded Zoll Medical Corporation, a foreign-owned, for-profit manufacturer of medical devices and software, a delivery order contract worth $1,287.44 for the supply of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 equipment. This contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 11, 2024, with an ultimate completion date of October 4, 2024. The contract has a fixed price with economic price adjustment pricing type and is not designated as...
The U.S. Defense Logistics Agency (DLA) awarded a $1,609.30 fixed-price delivery order contract to Zoll Medical Corporation, a foreign-owned, for-profit manufacturer of medical devices and software solutions. The contract, with no set-aside designation, is for the provision of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 medical equipment, which supports critical emergency care and patient monitoring across various federal agencies, including the Department of Veterans Affairs, Department of...
The U.S. Defense Logistics Agency (DLA) awarded Zoll Medical Corporation, a foreign-owned medical device manufacturer, a Delivery Order contract (Contract ID: SPE2D119D7003|SPE2D525F0037) valued at $1,680.30. The contract is for the delivery of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 devices, with a performance period ending on December 3, 2024. Zoll Medical, doing business as Zoll, is a for-profit organization that specializes in critical emergency care products, including defibrillators,...
The Department of Defense's Defense Logistics Agency (DLA) awarded a $1,609.30 firm-fixed-price, indefinite delivery contract to Zoll Medical Corporation, a foreign-owned manufacturer of medical devices, for the procurement of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 devices. This contract, which does not have a set-aside designation, is part of a larger $81 million single-award indefinite delivery contract (SPE2D122D0013) between Zoll and the DLA Troop Support Medical branch. The contract...
This is a federal contract award to Zoll Medical Corporation, a foreign-owned, for-profit medical device manufacturer, for the supply of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 products. The $2,049.74 fixed-price delivery order contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of August 20, 2025. Zoll Medical Corporation is a significant supplier of medical equipment to various federal agencies, particularly the Department of Veterans Affairs and DLA,...
This is a $1,609.30 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Zoll Medical Corporation, a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 medical devices and is not set aside. Zoll Medical Corporation is the prime contractor, and the contract is part of a larger $81 million Indefinite Delivery Contract with the DLA Troop Support Medical branch, which enables rapid...
The U.S. Defense Logistics Agency (DLA) has awarded a $1,287.44 fixed-price delivery order contract to Zoll Medical Corporation, a foreign-owned manufacturer of medical goods, to provide Microstream Advance Adult Oral-Nasal CO2 products. This delivery order is part of a larger $81 million Indefinite Delivery Contract (IDC) that DLA has with Zoll to procure a wide range of critical medical equipment and supplies, including ventilators, defibrillators, and patient monitors, to support military...
The Defense Logistics Agency Troop Support Medical branch has awarded Zoll Medical Corporation, a foreign-owned for-profit manufacturer, a delivery order contract worth $2,096.35 for the provision of MICROSTREAM ADVANCE ADULT-PEDIATRIC INTU medical devices. This order is issued against a larger Indefinite Delivery Contract (IDC) valued at over $81 million that Zoll holds with DLA to provide a variety of critical medical equipment and supplies, including ventilators, defibrillators, and patient...
This federal contract award, valued at $1,609.30, was issued by the Defense Logistics Agency (DLA) to Zoll Medical Corporation, a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 medical devices, with a completion date of July 31, 2025. The contract type is a Delivery Order with a Fixed Price and Economic Price Adjustment pricing structure. This contract award is not associated with a set-aside designation. Zoll...
The U.S. Defense Logistics Agency (DLA) awarded a $1,287.44 Fixed Price with Economic Price Adjustment contract to Zoll Medical Corporation, a foreign-owned manufacturer of medical devices and software solutions, to provide MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 equipment. This contract is a Delivery Order under the larger $81 million Indefinite Delivery Contract (IDC) SPE2D122D0013 that Zoll holds with the DLA Troop Support Medical branch. The IDC, awarded on September 28, 2022, is for the...
  • SPE2D119D7003
    Indefinite Delivery Contract
  • SPE2D119D7003-SPE2D524F408A
    Delivery Order

The U.S. Defense Logistics Agency awarded a $1,609.30 fixed-price delivery order contract to Zoll Medical Corporation, a foreign-owned, for-profit manufacturer of medical devices and software solutions, for the provision of MICROSTREAM ADVANCE ADULT ORAL-NASAL CO2 devices. The contract, which does not have a set-aside designation, was awarded on August 26, 2024 with a completion date of November 21, 2024. Zoll Medical Corporation, operating as Zoll, specializes in developing and marketing advanced medical technologies for defibrillation, circulation, ventilation, and fluid resuscitation. This award is part of a larger $81 million Indefinite Delivery Contract (IDC) that Zoll holds with the DLA Troop Support Medical branch, which enables the rapid procurement of Zoll's products to equip military treatment facilities and maintain healthcare readiness across multiple federal agencies, including the Department of Veterans Affairs, Department of Homeland Security, and National Park Service.

Generated 11/25/24, 9:11 AM